The immunohistochemical expression of programmed death ligand 1 (PD-L1) is affected by sample overfixation

7Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Humanized antibodies targeting programmed death receptor 1 (PD-1) or its ligand (PD-L1) have been approved for the treatment of different cancers. Some of these antibodies show a correlation between the tissue expression of PD-L1 and response. Evaluation of PD-L1 expression presents multiple challenges, but some preanalytical issues such as tissue fixation have been scarcely evaluated. With the hypothesis that immunohistochemical staining of PD-L1 may be impacted by the time of specimen fixation, we evaluated differences in its expression in tonsil samples exposed to predefined fixation times. Random nontumoral tonsillectomy specimens were blindly evaluated in tissue microarray slides after staining with SP142 and SP263 antibodies. With fixation times ranging from 12 to 72 hours, between 2.8% and 6.1% of the samples were considered to be suboptimally stained, with no differences between the 2 antibodies within these fixation times. A significantly higher proportion of samples exposed to a fixation time of 96 hours presented suboptimal immunostaining (15.6%, P<0.0001). In addition, suboptimally stained spots were 20.8% using SP142 and 10.4% using SP263 after 96 hours of fixation (P=0.046). In conclusion, the quality of staining for PD-L1 in tonsil samples decreased with overfixation of the specimen at times >72 hours. Samples exposed to formaldehyde for longer periods presented suboptimal results for both clones, but the SP142 antibody presented a significantly lower tolerance to formalin overexposure than SP263. These results indicate the relevance of a controlled preanalytical processing of samples and particularly the length of fixation of tumor specimens.

References Powered by Scopus

Pembrolizumab plus chemotherapy in metastatic non-small-cell lung cancer

5091Citations
N/AReaders
Get full text

Cancer immunoediting: Integrating immunity's roles in cancer suppression and promotion

4987Citations
N/AReaders
Get full text

The kappa statistic in reliability studies: Use, interpretation, and sample size requirements

3109Citations
N/AReaders
Get full text

Cited by Powered by Scopus

What do we have to know about pd-l1 expression in prostate cancer? A systematic literature review. part 1: Focus on immunohistochemical results with discussion of pre-analytical and interpretation variables

22Citations
N/AReaders
Get full text

The International Association for the Study of Lung Cancer Global Survey on Programmed Death-Ligand 1 Testing for NSCLC

20Citations
N/AReaders
Get full text

Optimized protocol for metabolomic and lipidomic profiling in formalin-fixed paraffin-embedded kidney tissue by LC-MS

18Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Barberà, A., Marginet Flinch, R., Martin, M., Mate, J. L., Oriol, A., Martínez-Soler, F., … Fernández, P. L. (2021). The immunohistochemical expression of programmed death ligand 1 (PD-L1) is affected by sample overfixation. Applied Immunohistochemistry and Molecular Morphology, 29(1), 76–81. https://doi.org/10.1097/PAI.0000000000000847

Readers' Seniority

Tooltip

Lecturer / Post doc 1

33%

PhD / Post grad / Masters / Doc 1

33%

Researcher 1

33%

Readers' Discipline

Tooltip

Medicine and Dentistry 1

25%

Biochemistry, Genetics and Molecular Bi... 1

25%

Social Sciences 1

25%

Materials Science 1

25%

Save time finding and organizing research with Mendeley

Sign up for free